Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Rang in aandelen #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Aandeelprijs
$0.14942078
Laatst gesynchroniseerd: 2025-05-15
Marktkapitalisatie
$3.86M
Verandering (1 dag)
0.10%
Verandering (1 jaar)
0.00%
Land
DE
Handel Medigene AG (MDG1)

Categorie

Winst voor Medigene AG (MDG1)
Winst in Jun 2024 TTM: $-16.77M
Volgens de meest recente financiële verslagen van Medigene AG bedraagt de huidige winst van het bedrijf $-16.77M. In 2022 behaalde het bedrijf een winst van $-10.06M, een stijging ten opzichte van de winst van 2021, die $-11.69M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Medigene AG van 2004 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-16.77M -8.57%
2023 $-18.34M 82.41%
2022 $-10.06M -14.01%
2021 $-11.69M -66.20%
2020 $-34.59M 54.79%
2019 $-22.35M -10.30%
2018 $-24.91M 60.47%
2017 $-15.53M 51.81%
2016 $-10.23M -33.71%
2015 $-15.43M 115.69%
2014 $-7.15M -49.32%
2013 $-14.11M -27.68%
2012 $-19.52M -2.57%
2011 $-20.03M -44.87%
2010 $-36.34M 15.53%
2009 $-31.45M -31.91%
2008 $-46.19M 0.82%
2007 $-45.82M 357.81%
2006 $-10.01M -29.67%
2005 $-14.23M -17.13%
2004 $-17.17M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$5.27B -31,555.72%
US
$1.95B -11,732.28%
NL
- -
CH
- -
KR
$3.01B -18,023.94%
BE